About us

The Coalition for Cancer

The Asia Society Policy Institute (ASPI) and the Memorial Sloan Kettering Cancer Center (MSK) have been working together since 2017 to enhance collaboration between the U.S., China, and the rest of the world in tackling the common enemy of cancer. This collaborative effort aims to accelerate the eradication of cancer as a major cause of death (or a cure for cancer) in a lifetime, through multi-stakeholder, multi-regional collaboration on patient-centric clinical trials and international regulatory harmonization.

Continuing the collaboration between ASPI and MSK, the Bloomberg New Economy International Cancer Coalition (the “Coalition”) was launched in 2021 at the Bloomberg New Economy Forum in Singapore. The Coalition brings together public-private sector leading representatives from academia, government regulatory agencies, the pharmaceutical and biotechnology industry, and patient advocacy groups across North America, Europe, and Asia. These global representatives advocate for strengthening international clinical trial collaboration in order to accelerate the development, access, and approval of cancer treatments and prevention that could save millions of lives. In the process, the Coalition also demonstrates the potential lifesaving results that can be the outcome of cooperation among experts in the United States, China, Europe, and beyond.

Partners and Supporters

Task Force

The Honorable Dr. Kevin Rudd

Former President & CEO, Asia Society; President Emeritus, Asia Society Policy Institute; Founding Chair, Center for China Analysis

    Dr. Bob Li

    Medical Oncologist and Physician Ambassador to China and Asia-Pacific, Memorial Sloan Kettering Cancer Center; Senior Fellow on Global Public Health, Center for China Analysis at the Asia Society Policy Institute.

      Jing Qian

      Co-Founder and Managing Director, Center for China Analysis at the Asia Society Policy Institute

        Dorrance Smith

        Senior Fellow on Global Public Health, Center for China Analysis at the Asia Society Policy Institute

          Morgan Speece

          Director of Operations, Asia Society Policy Institute; Project Manager, Center for China Analysis

            Yi Qin

            Junior Fellow on Global Public Health, Center for China Analysis at the Asia Society Policy Institute

              Funding and Support

              The Cure4Cancer International Clinical Trials Collaboration (C4C) public awareness initiative at Asia Society is supported by an unrestricted education grant from AstraZeneca.

              We would welcome other industry and philanthropic support for this non-profit international movement to accelerate the Cure4Cancer.